APA (7th ed.) Citation

Garwood, C. L., Cabral, K. P., Brown, R., & Dixon, D. L. (2024). Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review. Wiley. https://doi.org/10.1002/phar.4635

Chicago Style (17th ed.) Citation

Garwood, Candice L., Katherine P. Cabral, Roy Brown, and Dave L. Dixon. Current and Emerging PCSK9‐directed Therapies to Reduce LDL‐C and ASCVD Risk: A State‐of‐the‐art Review. Wiley, 2024. https://doi.org/10.1002/phar.4635.

MLA (9th ed.) Citation

Garwood, Candice L., et al. Current and Emerging PCSK9‐directed Therapies to Reduce LDL‐C and ASCVD Risk: A State‐of‐the‐art Review. Wiley, 2024. https://doi.org/10.1002/phar.4635.